In the midst of the Primal Challenge and provocative issues like insect eating, we’ve gotten away lately from our more “salty” side, shall we say. Truth be told, we realized this week that we haven’t quite felt like ourselves. We couldn’t put our proverbial finger on it until the realization set in. It was time, we decided, for a good, healthy rant.
And rant-worthy material was readily available, we might add. Little surprise here: it targets Big Pharma. (Ah, we’ve missed you, Big P.) This time we’re raising Cain about new research into the seemingly shoddy review and approval process for pharmaceutical drugs. The research report, which was presented at the American Sociological Association’s 103rd annual meeting this week, cited “fatal flaws in the way new drugs are tested and marketed.”